Curtis Michael P, Dwight Wesley, Pratt John, Cowart Marlon, Esbenshade Timothy A, Krueger Kathy M, Fox Gerard B, Pan Jia Bao, Pagano Thomas G, Hancock Arthur A, Faghih Ramin, Bennani Youssef L
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, IL 60064, USA.
Arch Pharm (Weinheim). 2004 Apr;337(4):219-29. doi: 10.1002/ardp.200300844.
Structure-activity relationships of homopiperazine-containing alkoxybiaryl nitriles employing various D-amino acid moieties and their N-furanoyl analogues were undertaken. This led to A-320436, a potent and selective non-imidazole H(3)-receptor antagonist possessing balanced affinity for both rat and human H(3)-receptors. This compound was shown to demonstrate in vitro and in vivo functional antagonism and is non-neurotoxic at doses (i.p.) up to 163 mg/kg in a general observation test.
研究了采用各种D-氨基酸部分及其N-呋喃甲酰类似物的含高哌嗪烷氧基联芳基腈的构效关系。这导致了A-320436的产生,它是一种强效且选择性的非咪唑H(3)受体拮抗剂,对大鼠和人类H(3)受体具有平衡的亲和力。该化合物在体外和体内均表现出功能性拮抗作用,并且在一般观察试验中,腹腔注射剂量高达163 mg/kg时无神经毒性。